Chemical Market Reporter - LIDOCAINE.
March 29, 1999 -- FDA has approved Lidoderm (lidocaine patch 5 percent), by Chadds Ford, Pa.-based Endo Pharmaceuticals Inc., for the treatment of pain associated...
American Family Physician - Combining triamcinolone and lidocaine for soft tissue injections
May 15, 2008 -- TO THE EDITOR: In the article on Dupuytren's disease, Drs. Trojian and Chu describe a procedure for injecting lidocaine 2% (Xylocaine) followed by...
Pediatric News - Lidocaine contact allergy may be increasing
May 1, 2007 -- AMELIA ISLAND, FLA. -- Lidocaine contact allergy may be on the rise, Dr. James S. Taylor said at a symposium sponsored by the Dermatology Foundation....
Journal of Drugs in Dermatology - Use of topical lidocaine for cosmetic dermatologic procedures
November 1, 2007 -- Abstract Topical anesthetic agents are frequently used by dermatologists to decrease the pain associated with a variety of cutaneous procedures,...
American Family Physician - Lidocaine patch for treatment of postherpetic neuralgia?
August 1, 2006 -- TO THE EDITOR: Although the article "Herpes Zoster and Postherpetic Neuralgia: Prevention and Managment" (1) in the September 15, 2005,...
American Family Physician - Systemic lidocaine or mexiletine for neuropathic pain
July 1, 2006 -- Clinical Question When used systemically, are lidocaine (Xylocaine) and its oral analogue mexiletine (Mexitil) safe and effective for the treatment...
Skin & Allergy News - More topical lidocaine means more dermatitis
May 1, 2007 -- AMELIA ISLAND, FLA. -- Lidocaine contact allergy may be on the rise, Dr. James S. Taylor said at a symposium sponsored by the Dermatology Foundation....
Business Wire - Columbia Laboratories Advances Clinical Development of Lidocaine Candidate
November 7, 2006 -- Vaginally-Administered Lidocaine under Development to Prevent and Treat Dysmenorrhea LIVINGSTON, N.J. -- Columbia Laboratories (NASDAQ: CBRX)...
Business Wire - Adolor Corporation Discontinues Development of Sterile Lidocaine Patch
October 31, 2006 -- EXTON, Pa. -- Adolor Corporation (Nasdaq:ADLR) announced today that the company has decided to no longer pursue clinical development of its sterile...
Business Wire - Columbia Laboratories Reports Results from Phase II Clinical Trial of Vaginally-administered Lidocaine for Dysmenorrhea
September 29, 2008 -- LIVINGSTON, N.J. -- Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced results from its Phase II study of vaginally-administered lidocaine,...
